Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Named Patient Program with levetiracetam oral solution in pediatric epilepsy patients from study N01148
2005-005078-55Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in epilepsy, sponsored by UCB. Primary endpoint: Safety and tolerability of long-term levetiracetam oral solution. Started Oct 2007; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2005-005078-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005078-55.